Peer Review History
| Original SubmissionDecember 16, 2020 |
|---|
|
PONE-D-20-39557 Projecting COVID-19 Isolation Bed Requirements for People Experiencing Homelessness PLOS ONE Dear Dr. Meyers, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 05 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Martial L Ndeffo Mbah, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2.) Thank you for stating the following financial disclosure: 'The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.' At this time, please address the following queries:
Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3.) We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 3 in your text; if accepted, production will need this reference to link the reader to the Table. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors developed a stochastic age- and risk- structured SEIR-like compartmental model of COVID-19 transmission in the Austin to project the number of isolation rooms that will be required to allow people experiencing homelessness to self-isolate while awaiting test results or through the infectious period. The authors projected the COVID-19 prevalence in Austin under seven reasonable intervention scenarios and sensitivity analysis for important parameter were done. Moreover, the authors showed that peak demand for PEH isolation bed to be roughly triple the projected peak daily incidence in the city, which is useful and easy for supporting decision making in other cities. The manuscript overall is well presented. The idea behind the work holds relevance and is of importance to public health. Some issues can be addressed to increase the clarity of this manuscript. 1. The main result (peak demand for PEH isolation bed) is highly dependent on the projected peak daily incidence in the city. I am wondering whether their model are calibrated and validated by the available data in Austin. If not, I would suggest that the authors at least to demonstrate some results regarding their models projection (e.g., projected daily incidence) in the manuscript or SI. 2. The authors assumed perfect test sensitivity and specificity i.e., p(infected|tested)=p(positive|tested), and I am wondering whether this assumption would greatly affect the results or not. Please clarify. As the authors stated in the manuscript, their estimates are highly sensitive to the speed of COVID-19 testing and truly infection prevalence for PEH. At early stage (March to July), the detection/test rates are quite low. In the future, under a more strict quarantine/contact tracing policy, far more isolation beds would be required. However, the work did provide a nice framework to inform real-time provisioning to protect vulnerable PEH populations. Reviewer #2: Dear Authors, I think you address an important aspect of pandemic management in a population that often overlooked. The writing and presentation of the work is solid and the methods are appropriate. A few remarks: 1. I am confused by the parameter k. According to figure S3, there is no difference in bed demand in the first 4 weeks past simulation start if someone gets infected and waits 2 days to get tested (and start isolating) or if someone waits 10 days to get tested and start isolating. Over the first 4 months, it appears that waiting longer to get tested (and begin isolating) slightly decreases the total number of beds needed. This seems counterintuitive to me, given that an infected person would presumably infect many more people over 10 days than over 2. 2. In Figure 2, incidence is listed as a percentage, which is quite unusual. Is this the percentage of the PEH population that is infected? Should this be cases per 100 persons? I don't know how to interpret this value. 3. The ongoing surge of COVID-19 in Texas probably changes suitable parameters of this model quite a bit (in recent weeks, the highest percentage of positive tests was 22%, more than double the assumed value here), and might make the overall rule of thumb less applicable. I realize that this is a situation in constant flux, but I think it would be useful to address, even briefly, how projections are different now than they were in July. How many isolation beds are in use in Austin? How many are needed? My few suggestions to improve the readability of the manuscript: 1. I would consider moving some of the tables S2 and S3 from Appendix 2 material into the Methods section, so I don't have to immediately dig for the supplemental materials to see how you structured the model. 2. On lines 134 and 137, N(sub)H is very hard to read and looks (in the .pdf) like N(sub)pi. A different font for the formula might make this easier to distinguish. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Qimin Huang Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Projecting COVID-19 Isolation Bed Requirements for People Experiencing Homelessness PONE-D-20-39557R1 Dear Dr. Meyers, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Martial L Ndeffo Mbah, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-39557R1 Projecting COVID-19 Isolation Bed Requirements for People Experiencing Homelessness Dear Dr. Meyers: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Martial L Ndeffo Mbah Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .